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INTRODUCTION:  Surgeons  often  perform  surgery  for  patients  who  are  critically  ill.  Intensive  care  unit
(ICU)-acquired  weakness  (ICUAW)  is a  condition  in which  systemic  and  prolonged  muscle  weakness
occurs  and  causes  worse  short-term  and  long-term  outcomes.
PRESENTATION  OF  CASE:  A  60-year-old  woman  with  sudden  nausea  and  vomiting  presented  to our  hos-
pital and  developed  shock.  Abdominal  CT showed  thickness  of  the  descending  colon  and  ascites.  She
was  diagnosed  with  sepsis  due  to descending  colon  cancer.  Colectomy  of the  descending  colon  was  per-
formed  due to  necrosis,  and a stoma  was  created.  After  surgery,  she  received  intensive  care  in the  ICU.
It  was  difﬁcult  to  wean  her from  the  ventilator,  and  she  developed  severe  ﬂaccid  weakness  of the  limbs.
Her Medical  Research  Council  (MRC)  sum  score  was  0.  Since  other  organic  disorders  causing  prolonged
paralysis  were  excluded,  she  was  ﬁnally  diagnosed  as  having  ICUAW.  Active  rehabilitation,  nutritional
support,  and  glycemic  control  were  continued.  Now,  6 months  after  surgery,  her MRC  score  has  improved
to  30.
DISCUSSION:  The  treatment  for ICUAW  has  been  reported  to  include  recovery  from  the  critical  illness,  early
rehabilitation,  and  nutritional  support,  and  it  requires  close  cooperation  among  health  care  providers.
CONCLUSION:  All  physicians  and  surgeons  who  care  for critically  ill patients  should  take  active  steps  to
diagnose  ICUAW  in  order to  avoid  deterioration  of  patients’  activities  of daily  living.
©  2016  The  Author(s).  Published  by  Elsevier  Ltd  on behalf  of IJS  Publishing  Group  Ltd.  This  is  an  open
he  CCaccess  article  under  t
. Introduction
It has been reported that marked loss of muscle strength can
ccur in patients with life-threatening infections [1], and this may
lso cause an ongoing disorder of function and loss of QOL after
ischarge from hospital [2]. Intensive care unit-acquired weakness
ICUAW) is such a neuromuscular disorder caused by severe illness
reated in the ICU [3]. ICUAW has been reported to occur in various
Abbreviations: ICUAW, ICU-acquired weakness; MRC, Medical Research Council.
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patients, and early rehabilitation is considered very important to
prevent prolonged muscle weakness [4,5]. However general sur-
geons still seem to be insufﬁciently aware of this clinical condition.
A case of ICUAW after severe sepsis is presented.
2. Presentation of case
A 60-year-old woman  with sudden nausea and vomiting pre-
sented to our hospital. She was on steroid treatment for malignant
lymphoma. She had pain in the left side of the abdomen, and a large
mass was  palpable. There was  no muscular guarding or rebound
tenderness. Laboratory data showed increased inﬂammation and
marked acidosis (Table 1). Abdominal CT showed thickness of the
descending colon, swelling of surrounding lymph nodes, and ascites
(Fig. 1a, b). Her blood pressure and level of consciousness decreased
gradually. She was diagnosed with sepsis due to descending colon
cancer. Colectomy of the descending colon was performed due
to necrosis, and a stoma was created (Fig. 1c). After surgery, the
patient was  admitted to the intensive care unit for general care. In
the ICU, she received not only treatment for the primary disease,
Group Ltd. This is an open access article under the CC BY-NC-ND license (http://
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Table 1
Laboratory data before surgery.
Peripheral blood
RBC 5.54 × 104/mm3
Hg 12.7 g/dl
Hct 43.1%
WBC  50800/mm3
Plt 8.0 × 104/mm3
Biochemistry
T-Bil 0.4 mg/dl
AST 106 IU/l
ALT 71 U/l
LDH 571 IU/l
ALP 155 U/l
CK 139 IU/l
AMY  82 82 mg/dl
Na 135 mg/dl
K  5.3 mg/dl
Cl 120 mg/dl
BUN 34 mg/dl
Cr 2.74 mg/dl
TP  5.4 g/dl
Alb 3.8 g/dl
Procalcitonin 0.635 ng/ml
Coagulation system
PT(%) 17%
PT-INR 4.15
APTT unmeasurable
AT-III 21%
FDP 44.6 g/ml
D-dimer 18.2 g/ml
Blood sugar
BS 145 mg/dl
Blood gases (O2 10 l)
pH 6.889
PO2 455 mmHg
PCO2 26.1 mmHg
HCO3 −4.7 mmol/l
BE −28.2 mmol/l
Lactate 13.2 mmol/l
Fig. 1. Abdominal CT on admission and excised specimen ﬁndings. Abdominal CT shows t
(a,  b). A large tumor with necrosis is located in the descending colon. Lymph nodes surroPEN  ACCESS
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but also early rehabilitation to prevent muscle atrophy. Though
she recovered from multiple organ failure, she had difﬁculty in
being weaned from the ventilator, and a tracheotomy was per-
formed on postoperative day 12. Her level of consciousness was
GCS4 (E4VTM0). There was  no anisocoria, abnormal light reﬂex,
disorder of eye movement, or facial muscle paralysis. She then
developed severe ﬂaccid weakness of the limbs and diminished
deep tendon reﬂexes. Her Medical Research Council (MRC) sum
score was 0. Head CT showed no abnormalities causing muscle
weakness (Fig. 2). She was diagnosed as having ICUAW from the
clinical course and the pathophysiological ﬁndings, including the
MRC  score. Active rehabilitation, nutritional support, and glycemic
control were continued. Now, 6 months after surgery, her MRC
score has improved to 50 (Fig. 3).
3. Discussion
The mortality rate of sepsis in the ICU has improved due to
the development of intensive treatment. Currently, not only short-
term outcomes, but also long-terms outcomes are being considered
during critical care.
In the nineteenth century, loss of ﬂesh and strength in patients
with life-threatening disease was reported [6]. In 2009, Stevens
and colleagues reported a framework for diagnosing and classi-
fying ICUAW [7]. The diagnostic criteria for ICUAW are practical,
based on history and clinical examination: (1) generalized weak-
ness developing after the onset of critical illness; (2) weakness is
diffuse (involving both proximal and distal muscles), symmetric,
ﬂaccid, and generally spares cranial nerves; (3) MRC  sum score
<48, or mean MRC  score <4 in all testable muscle groups noted
on more than two occasions separated by >24 h; (4) dependence
on mechanical ventilation; and (5) causes of weakness not related
to the underlying critical illness excluded. To make a deﬁnitive
diagnosis of ICUAW, costly or invasive tests such as electromyo-
graphy, single-nerve condition studies, muscle biopsy, and muscle
ultrasound are required. However, obtaining complete data from
hickness of the descending colon, swelling of surrounding lymph nodes, and ascites
unding the tumor show bulky swelling (c).
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lFig. 2. Head CT. Head CT shows no abnormalities causing muscle weakness.
ritically ill patients at the bedside remains challenging because
f tissue edema and electrical interference [8]. The current patient
resented with systemic weakness that spared the cranial nerves
fter emergency surgery for acute abdomen. She had an MRC  sum
core of 0 and could not be weaned off mechanical ventilation.
ince various examinations could not identify an organic cause for
aralysis, a presumptive diagnosis of ICUAW was  made.
It has been reported that about 26–65% patients who  require
echanical ventilation have weakness on awakening [4,5], and the
onger the patients are ventilated, the higher the incidence of mus-
le weakness [9].The clinical condition and pathogenesis of ICUAW have not been
ully determined. However, it has been reported that the humoral
mmune reaction due to a severe condition such as septic shock,
ultiple organ failure, and acute respiratory distress syndrome
ig. 3. Clinical course. MRC: Medical Research Council, CMV: continuous mandatory ven
ation,  PPN: peripheral parenteral nutrition, TPN: total parenteral nutrition.PEN  ACCESS
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plays an important role in the development of ICUAW [4]. The pro-
duction of various types of cytokines leads to degeneration of nerve
conduction, microvascular hyperpermeability due to degeneration
of microvessels, and production of neurotoxic agents. In addition,
muscle breakdown is directly affected by metabolic disease, inﬂam-
matory changes, and loss of energy [10]. In ICUAW patients, not
only skeletal muscle, but also the diaphragm can be affected [11].
Thus, such patients usually fail weaning off mechanical ventila-
tion that cannot be explained by their respiratory and circulatory
status.
ICUAW is often characterized by symmetrical weakness of the
limbs that affects proximal muscles more than distal muscles [12].
The function of cranial nerves is usually unaffected [13]. Thus,
patients with ICUAW typically grimace with painful stimuli but
show no withdrawal of the limbs. The present patient showed a
prolonged need for mechanical ventilation despite improvement
of her general condition. In addition, she showed a discrepancy
between the facial muscles and core muscles, as discussed above.
ICUAW is associated with delayed weaning from ventilation,
longer ICU stay, and increased ICU/hospital mortality [14]. In a
recent study, patients with weakness showed a decline over time
from 36% at hospital discharge to 22% at 3 months, 7–15% at 6
months, 4–14% at 1 year, and 9% at 2 years [15]. In general, sep-
tic patients with multiple organ failure have a high mortality, up to
60% [16]. Among the survivors, patients whose general condition
improves in the relatively early phase tend to avoid worsening of
ADL on a long-term basis [4]. Thus, the main risk factor for ICUAW
appears to be the severity of illness. Therefore, early and rigor-
ous intensive care is crucial to decrease mortality and improve
long-term outcomes [17]. Another study reported that sarcopenia,
use of vasopressors, corticosteroids, neuromuscular blockage, and
aminoglycoside therapy, immobilization, and hyperglycemia were
independent risk factors for neuromuscular complications [8,18]. In
the present case, the patient had extremely severe septic shock and
required prolonged use of vasopressors, and her muscle weakness
did not recover for a long time.
There are no speciﬁc therapeutic options for preventing or treat-
ing ICUAW. Risk factor avoidance or modiﬁcation might reduce the
severity and risk of ICUAW. One aspect of treatment for ICUAW
is prevention of contractures and pressure ulcers by early reha-
bilitation and frequent position changes [19]. Malnutrition was
originally considered a contributor to ICUAW, so early tube feeding
should be considered [20].
tilation, CPAP + PSV: continuous positive airway pressure + pressure support venti-
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Jolley and colleague reported that critical illness can be catego-
ized into four phases: pre-ICU, early ICU, late ICU, and post ICU
8]. They suggested that assessment and interventions targeting
ndividualized stages could be an effective strategy.
The concept of ICUAW has been generally recognized among
ntensive care clinicians, and many reports have been published in
he ﬁeld of critical care. However, few studies have been reported
n the ﬁeld of general surgery [21]. Thus, it is important to collabo-
ate with healthcare providers such as nurses, nutritional support
eams, and physical therapists to prevent the development of
CUAW. ICUAW should be diagnosed earlier, and appropriate pre-
ention and management could prevent a decrease in long-term
DL.
. Conclusion
Surgeons commonly operate on patients with critical illnesses,
nd ICUAW is not rare condition in such patients. All physicians who
are for critically ill patients should take active steps to diagnose
CUAW in order to avoid decreases in patients’ ADL.
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